Abstract
Background
The prevention of neural tube defects (NTDs) is now an issue of major public health concern. Myelomeningocele, the most common NTD, often results in severe disabilities and may be life threatening. In Africa, there is little awareness of the NTDs, and most African countries lag behind in the global efforts at preventing them.
Purpose
Following a review of global literature, we discuss the burden of myelomeningocele on the society and the current state of its prevention with an emphasis on Africa within the global context. The realization that folate supplementation reduces the occurrence of NTDs by as much as 85 % offers an opportunity to promote global reduction in the incidence of NTDs through (1) effective folate supplementation strategies combined with (2) secondary prevention using prenatal detection and termination of NTD pregnancies within respective national legal frameworks. We call attention to the poor state of understanding of NTDs in Africa and the alarming rarity of policies to prevent the condition in the continent.
Conclusions
The understanding of the contributions of folate deficiency to the causation of NTDs has enabled appropriate, though still inadequate, preventive measures to be taken in several countries. We call on African governments and the international community to rapidly promote policies aimed at making fortification of wheat (and or other substitute staple foods) with folic acid universally available.
Similar content being viewed by others
References
Gaskill SJ, Hudgins RJ (2004) Myelomeningocele. Neurosurg Focus 16(2):1
Hadzagic-Catibusic F, Maksic H, Uzicanin S, Heljic S, Zubcevic S, Merhemic Z, Cengic A, Kulenovic E (2008) Congenital malformations of the central nervous system: clinical approach. Bosn J Basic Med Sci 8(4):356–360
Miles M (2006) Children with spina bifida and hydrocephalus in Africa: can medical, family and community resources improve the life chances? http://www.independentliving.org/docs7/miles200609.html. Accessed 1 February 2013
Padmanabhan R (2006) Etiology, pathogenesis and prevention of neural tube defects. Cong Anom 46:55–67
Volcik KA, Blanton SH, Kruzel MC, Townsend IT, Tyerman GH, Mier RJ, Northrup H (2002) Testing for genetic associations in a spina bifida population: analysis of the HOX gene family and human candidate gene regions implicated by mouse models of neural tube defects. Am J Med Genet 110:203–207
Frey L, Hauser WA (2003) Epidemiology of neural tube defects. Epilepsia 44(suppl 3):4–13
Kaufman BA (2004) Neural tube defects. Pediatr Clin N Am 51:389–419
Ceizel AE, Dudas I (1992) Prevention of first occurrence of neural-tube defects by periconceptional vitamin supplementation. NEJM 327:1832–1835
Lawrence KM, James M, Miller MH, Tennant GB, Campbell H (1981) Double blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 282:1509–1511
Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ (1990) Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 10:149–152
MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131–137
Aqrabawi HE (2005) Incidence of neural tube defect among neonates at King Hussein Medical Center Jordan. East Mediterr Health J 11(4):819–823
Crowe CA, Heuther CA, Oppenheimer SG, Barth LD, Jeffrey E, Reinhart S (1985) The epidemiology of spina bifida in south-western Ohio–1970–1979. Dev Med Child Neurol 27(2):176–182
Elwood JM, Elwood JH (1980) Epidemiology of anencephaly and spina bifida. New York Press, New York, pp. 85–119
Jorde LB, Fineman RM, Martin RA (1984) Epidemiology of neural tube defects in Utah. Am J Epidemiol 119:487–495
Flood T, Brewster M, Harris J, Keefer S, Merz R, Howe H, Hanson J, Panny S, Bakewell J, Seeland M, Costa P, Olsen C, Murray A, Marazita M, Hill C (1992) Spina bifida incidence at birth—United States, 1983–1990. MMWR CDC Surveill Summ 41:497–500 http://wonder.cdc.gov/wonder/prevguid/m0017197/m0017197.asp. Accessed 10 February 2013
Ferembach D (1963) [Anthropology] Frequency of spina bifida occulta in prehistoric human skeletons. Nature 199(4888):100–101
Charon P (2005) Teratologie du tube neural: histoire et paleopathologie. Antropo 10:83–101 http://www.didac.ehu.es/antropo/10/10-8/Charon.htm (Accessed February 10, 2013)
Adeloye A, Oyewole A, Adeyokunnu AA (1985) Epidemiology of Spina Bifida Cystica in Nigeria. Ital J Paediatr Neurosci 1:137–148
Henry APJ, Mickel RE (1974) Spina bifida in African and Indian babies. J Bone Joint Surg 56 B(4):650–657
Airede KI (1992) Neural tube defects in the middle belt of Nigeria. J Trop Pediatr 38:27–30
Njamnshi AK, de Paul DV, Lekoubou A, Guemse M, Obama MT, Mbu R, Takongmo S, Kago I (2008) Neural tube defects are rare among Black Americans but not in Sub-Saharan Black Africans: the case of Yaounde—Cameroon. J Neurol Sci 270:13–17
Alatise OI, Adeolu AA, Komolafe EO (2006) Pattern and factors affecting management outcome of spina bifida cystica in Ile-Life. Nigeria. Pediatr Neurosurg 42(5):277–283
Sanoussi S (2001) Les malformations du tube neural au Niger: a propos de 387 cas en 10 ans. Plaidoyer pour un traitement par l'acide folique en periode peri-conceptionnelle. Med Afr Noire 48:509–515
Doumbouya N, Camara F (1999) Mortalite dans le service de chirurgie pediatrique au Chu de Donka. Med Afr Noire 46(12):589–592
Ouatara O (1997) Les myelomenigoceles en Afrique: cas de la Cote d'ivoire. Med Afr Noire 44(7):402–404
Adeleye AO, Dairo MD, Olowookere KG (2010) Central nervous system congenital malformations in a developing country: issues and challenges against their prevention. Childs Nerv Syst 26:919–924
Adeleye AO, Olowookere KG (2009) Central nervous system congenital anomalies: a prospective neurosurgical observational study from Nigeria. Congenit Anom (Kyoto) 49(4):258–261
Taye K, Bedru A (2009) Pattern of neural tube defects at Tikur Anbessa Hospital, Addis Ababa, Ethiopia. Ethiop Med J 47(1):71–76
Rabiu TB (2009) Neural tube defects in the African child. J Neurol Sci 280(1–2):131
de Paul DV, Bissek AZ, Njamnshi AK (2009) Neural tube defects in the African child: a commentary. J Neurol Sci 280(1–2):131–132
Adeloye A (1995) Spina bifida cystica in the African. AJNS 14(2)
Adeloye A (1971) The pattern and problems of spina bifida cystica at Ibadan, Nigeria. Dev Med Child Neurol Suppl 25:15–18
Olumide AA, Adeloye A (1980) Management of spina bifida cystica at Ibadan. Niger J Paediatr 7:46–50
Mezue WC, Eze CB (1992) Social circumstances affecting the initial management of children with myeolomeningocele in Nigeria. Dev Med Child Neurol 34:338–341
Valenca MP, de Menezes TA, Calado AA, de Aguiar CG (2012) Burden and quality of life among caregivers of children and adolescents with meningomyelocele: measuring the relationship to anxiety and depression. Spinal Cord 50(7):553–557
Oakeshott P, Hunt GM (2003) Long-term outcome in open spina bifida. Br J Gen Pract 53:632–636
Tuli S, Tuli J, Drake J, Spears J (2004) Predictors of death in pediatric patients requiring cerebrospinal fluid shunts. J Neurosurg Pediatr 100:442–446
Ouyang L, Grosse SD, Armour BS, Waitzman NJ (2007) Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res (Part A) 79:552–558
Harris MB, Banta JB (1990) Cost of skin care in the myelomeningocele population. J Pediatr Orthop 10:355–361
Cassell CH, Grosse SD, Thorpe PG, Howell EE, Meyer RE (2011) Health care expenditures among children with and those without spina bifida enrolled in Medicaid in North Carolina. Birth Defects Res A Clin Mol Teratol 91(12):1019–1027
Sambo LG, Kirigia JM, Ki-Zerbo G (2011) Health financing in Africa: overview of a dialogue among high level policy makers. BMC Proc 5(Suppl 5):S2
Kirigia JM, Nganda BM, Mwikisa CN, Cardoso B (2011) Effects of global financial crisis on funding for health development in nineteen countries of the WHO African Region. BMC Int Health Hum Rights 11:4
Rabiu TB, Tiamiyu LO, Awoyinka BS (2012) Awareness of spina bifida and periconceptional use of folic acid among pregnant women in a developing economy. Childs Nerv Syst 28:2115–2119
Mulinare J, Cordero JF, Erickson JD, Berry RJ (1988) Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141–3145
Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W (1989) Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847–2852
Rasmussen LB, Andersen NL, Andersson G, Lange AP, Rasmussen K, Skak-Iversen L, Skovby F, Ovesen L (1998) Folate and neural tube defects. Recommendations from a Danish working group. Dan Med Bull 45(2):213–217
Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A (1999) Prevention of neural-tube defects with folic acid in China. China—U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341(20):1485–1490
Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41(RR-14):1–7
Rasmussen SA, Erickson JD, Reef SE, Ross DS (2009) Teratology: from science to birth defects prevention. Birth Defects Res A Clin Mol Teratol 85:82–92
Eichholzer M, Tonz O, Zimmermann R (2006) Folic acid: a public-health challenge. Lancet 367(9519):1352–1361
Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, Mikkelsen TB, Michaelsen KF, Olsen SF (2004) Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr 7:843–850
Food and Drug Administration (1996) Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61:8781–8807
Oakley GP Jr, Johnston RB Jr (2004) Balancing benefits and harms in public health prevention programmes mandated by governments. BMJ 329:41–43
Bower C, Miller M, Payne J, Serna P, de Klerk N, Stanley FJ (2004) Folate promotion in Western Australia and the prevention of neural tube defects. Aust N Z J Public Health 28:458–464
Canada H (1997) Regulations amending the Food and Drug Regulations (1066). Can Gaz Part 1(131):3702–3737
Castilla EE, Orioli IM, Lopez-Camelo JS, Dutra Mda G, Nazer-Herrera J, Latin American Collaborative Study of Congenital Malformations (ECLAMC) (2003) Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet A 123:123–128
Safdar OY, Al-Dabbagh AA, AbuElieneen WA, Kari JA (2007) Decline in the incidence of neural tube defects after the national fortification of flour (1997–2005). Saudi Med J 28(8):1227–1229
Cameron M, Moran P (2009) Prenatal screening and diagnosis of neural tube defects. Prenat Diagn 29(4):402–411
Blaas HG, Eik-Nes SH, Isaksen CV (2000) The detection of spina bifida before 10 gestational weeks using two- and three-dimensional ultrasound. Ultrasound Obstet Gynecol 16(1):25–29
Khoshnood K, Greenlees R, Loane M, Dolk H (2011) On behalf of the EUROCAT Program Management Committee and a EUROCAT working group Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol 91(Suppl 1):S16–S22
Busby A, Abramsky L, Dolk H, Armstrong B (2005) Eurocat Folic Acid Working Group. Preventing neural tube defects in Europe: Population based study. BMJ 330:574–575
Chan A, Pickering J, Haan E, Netting M, Burford A, Johnson A, Keane RJ (2001) “Folate before pregnancy”: the impact on women and health professionals of a population-based health promotion campaign in South Australia. Med J Aust 174:631–636
McDonnell RJ, Johnson Z, Delaney V, Dack P (1999) East Ireland 1980–94: epidemiology of neural tube defects. J Epidemiol Community Health 53:782–788
Djientcheu VP, Njamnshi AK, Wonkam A, Njiki J, Guemse M, Mbu R, Obama MT, Takongmo S, Kago I, Tetanye E, Tietche F (2008) Management of neural tube defects in a Sub-Saharan African country: the situation in Yaounde, Cameroon. J Neurol Sci 275:29–32
Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B (2008) Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 82:211–216
Cornel MC, Erickson JD (1997) Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 55:134–137
Bell KN, Oakley GP Jr (2009) Update on prevention of folic acid preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 85(1):102–107
Flour Fortification Initiative. http://www.ffinetwork.org/regional_activity/africa.php. Accessed 17 February 2013
Oakley GP Jr (2009) Epidemiology: The scientific basis for creating political will to prevent Spina Bifida andimprove the lives of persons with the condition. In: The Future is now; First World Congress on Spina Bifida Research and Care, Florida; 21–24. http://www.cdc.gov/ncbddd/orders/pdfs/207256-A_SpinaBifida_11_13FinalProof.pdf. Accessed 10 February 2013
Rabiu TB (2009) Improving health research. Lancet 373(9659):213–214
Rabiu TB, Balogun JA (2009) Repositioning health research in developing countries. Arch Med Res 40:223
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rabiu, T.B., Adeleye, A.O. Prevention of myelomeningocele: African perspectives. Childs Nerv Syst 29, 1533–1540 (2013). https://doi.org/10.1007/s00381-013-2126-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-013-2126-4